| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
3,280,000 |
| Market
Cap: |
1.13(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.3437 - $4 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Longeveron is a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions. Co.'s primary investigational product is the LOMECEL-B™ cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. Co. is sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome, and hypoplastic left heart syndrome.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
297,872 |
322,872 |
322,872 |
322,872 |
| Total Buy Value |
$699,999 |
$734,301 |
$734,301 |
$734,301 |
| Total People Bought |
3 |
6 |
6 |
6 |
| Total Buy Transactions |
5 |
9 |
9 |
9 |
| Total Shares Sold |
0 |
0 |
23,532 |
219,987 |
| Total Sell Value |
$0 |
$0 |
$81,541 |
$1,060,824 |
| Total People Sold |
0 |
0 |
1 |
3 |
| Total Sell Transactions |
0 |
0 |
3 |
10 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ross Cathy |
|
– • – |
2021-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
| Borger Erin |
|
– • – |
2021-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
| Losordo Douglas W |
|
– • – |
2021-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
| Hare Joshua |
Chairman & CSO |
• • • |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
53,514 |
|
- |
|
| Hare Joshua |
Chairman & CSO |
• • • |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,895,428 |
|
- |
|
| Green Geoff |
CEO |
• – – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
174,429 |
|
- |
|
| Hare Neil E |
|
– • – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
894 |
|
- |
|
| Hare Neil E |
|
– • – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
53,514 |
|
- |
|
| Soffer Donald M |
|
– • – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,772,902 |
|
- |
|
| Soffer Donald M |
|
– • – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
53,514 |
|
- |
|
| Lehr Paul T |
General Counsel, Secretary |
• – – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
147,201 |
|
- |
|
| Borger Erin |
|
– • – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,836 |
|
- |
|
| Clavijo James |
CFO and Treasurer |
• – – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
93,650 |
|
- |
|
| Soffer Rock |
|
– • – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
26,757 |
|
- |
|
| Ds Med Llc |
|
– – • |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,772,902 |
|
- |
|
115 Records found
|
|
Page 5 of 5 |
|
|
